Eli Lilly and Company
All drugs.
Search drugs by brand or generic name, or refine the directory by prescription status, class, indication, manufacturer, and specialty.
Enter at least 3 characters to search the full directory.
Results
Eli Lilly and Company
REZVOGLAR KWIKPEN (insulin glargine-aglr)
INTERMEDIATE-, LONG-ACTING, AND COMBINATION INSULINS · TYPE 2 DIABETES MELLITUS ·+1
Eli Lilly and Company
OMVOH (mirikizumab-mrkz)
INTERLEUKIN 23 ANTAGONISTS · CROHN'S DISEASE ·+1
Eli Lilly and Company
OMVOH PEN (mirikizumab-mrkz)
INTERLEUKIN 23 ANTAGONISTS · CROHN'S DISEASE ·+1
Eli Lilly and Company
ZEPBOUND (tirzepatide)
DIET AIDS · OBSTRUCTIVE SLEEP APNEA SYNDROME ·+2
Eli Lilly and Company
KISUNLA (donanemab-azbt)
ALZHEIMER'S DISEASE AGENTS - AMYLOID DIRECTED MC ANTIBODY · ALZHEIMER'S DISEASE
Eli Lilly and Company
EBGLYSS PEN (lebrikizumab-lbkz)
ECZEMA AGENTS SYSTEMIC INTERLEUKIN-13 (IL-13)ANTAG.MAB
Eli Lilly and Company
EBGLYSS SYRINGE (lebrikizumab-lbkz)
ECZEMA AGENTS SYSTEMIC INTERLEUKIN-13 (IL-13)ANTAG.MAB
Eli Lilly and Company
INSULIN LISPRO JUNIOR KWIKPEN (insulin lispro)
SHORT-ACTING INSULINS · TYPE 2 DIABETES MELLITUS ·+2
Eli Lilly and Company
INSULIN LISPRO PROTAMINE MIX (insulin lispro protamine and insulin lispro)
INTERMEDIATE-, LONG-ACTING, AND COMBINATION INSULINS · TYPE 2 DIABETES MELLITUS ·+2
Eli Lilly and Company
LYUMJEV (insulin lispro-aabc)
SHORT-ACTING INSULINS · TYPE 2 DIABETES MELLITUS ·+2
Eli Lilly and Company
LYUMJEV KWIKPEN U-100 (insulin lispro-aabc)
SHORT-ACTING INSULINS · TYPE 2 DIABETES MELLITUS ·+2
Eli Lilly and Company
LYUMJEV KWIKPEN U-200 (insulin lispro-aabc)
SHORT-ACTING INSULINS · TYPE 2 DIABETES MELLITUS ·+2
Eli Lilly and Company
TAUVID PATIENT READY DOSE (flortaucipir F-18)
DIAGNOSTIC IMAGING
Eli Lilly and Company
INLURIYO (imlunestrant tosylate)
ANTIESTROGEN · ER-POSITIVE, HER2-NEGATIVE, ESR1-MUTATED BREAST CANCER
Eli Lilly and Company
ZEPBOUND KWIKPEN (tirzepatide)
DIET AIDS · OBSTRUCTIVE SLEEP APNEA SYNDROME ·+2
Eli Lilly and Company
FOUNDAYO (orforglipron calcium)
DIET AIDS · WEIGHT LOSS MANAGEMENT FOR OBESE PATIENT (BODY MASS INDEX 30 OR GREATER) ·+1
Eli Lilly and Company